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Abstract
Background:  Serum response factor (SRF), a member o f  t h e  M A D S  b o x  f a m i l y  o f  n u c l e a r
transcription factors, plays an important role in cardiovascular development and function.
Numerous studies demonstrate a central role for SRF in regulating smooth and cardiac muscle cell
gene expression. Consistent with this, loss of SRF function blocks differentiation of coronary
vascular smooth muscle cells from proepicardial precursors, indicating SRF is necessary for
coronary vasculogenesis. The role of SRF in endothelial cell contribution during early vascular
development, however, has not been addressed. To investigate this, we generated transgenic mice
lacking expression of SRF in endothelial cells. Mice expressing Cre recombinase (Tie2Cre+) under
Tie2  promoter control were bred to mice homozygous for Srf  alleles containing loxP
recombination sites within the Srf  gene (Srff/f). Tie2 is a tyrosine kinase receptor expressed
predominantly on endothelial cells that mediates signalling during different stages of blood vessel
remodelling. Resulting embryos were harvested at specific ages for observation of physical
condition and analysis of genotype.
Results: Tie2Cre+/-Srff/f embryos appeared to develop normally compared to wild-type littermates
until embryonic day 10.5 (E10.5). Beginning at E11.5, Tie2Cre+/-Srff/f  embryos exhibited
cerebrovascular hemorrhaging and severely disrupted vascular networks within the yolk sac.
Hemorrhaging in mutant embryos became more generalized with age, and by E14.5, most Tie2Cre+/
-Srff/f embryos observed were nonviable and grossly necrotic. Hearts of mutant embryos were
smaller relative to overall body weight compared to wild-type littermates. Immunohistochemical
analysis revealed the presence of vascular endothelial cells; however, vessels failed to undergo
appropriate remodelling. Initial analysis by electron microscopy suggested a lack of appropriate cell-
cell contacts between endothelial cells. Consistent with this, disrupted E-cadherin staining patterns
were observed in mutant embryos.
Conclusion: These results provide the first in vivo evidence in support of a role for SRF in
endothelial cell function and strongly suggest SRF is required for appropriate vascular remodelling.
Background
Serum response factor (SRF) is a nuclear transcription fac-
tor of the MADS (MCM1, Agamous, Deficiens, SRF) box
family. SRF interacts as a dimer with DNA at the serum
response element (SRE), a 10 base pair AT-rich sequence
[CC(AT)6GG] also known as the CArG box (for review see
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[1,2]). The SRE sequence is present in a wide variety of
genes, including those encoding for immediate early pro-
teins (e.g. Fos, Jun, HSP70), neuronal nuclear receptors
(e.g. Nurr1, Nur77) and numerous contractile and
cytoskeletal proteins (eg. actins, myosins). Expression of
SRF is essential in early development as SRF-null embryos
die during gastrulation [3]. SRF is required for develop-
ment of mesoderm [3]. The expression pattern of genes
under SRF control is regulated in a combinatorial fashion
by SRF's ability to interact with a variety of accessory fac-
tors such as Elk-1 and SAP-1 to regulate expression of
genes involved in cell growth and proliferation, and myo-
cardin and related family factors to control myogenic gene
expression (for review see [4]).
SRF plays a critical role in myogenesis. Early studies estab-
lished the expression of SRF in cells of the myogenic line-
age [5-7], and SRF has been shown to be required for
appropriate skeletal, cardiac and smooth muscle cell
growth and differentiation [8,9]. SRF gene knockout stud-
ies from our laboratory indicate that disruption of SRF in
cardiomyocytes leads to severe defects in the contractile
apparatus, including Z-disc and stress fiber formation, as
well as mislocalization and/or attenuation of sarcomeric
protein expression [10]. Consistent with these observa-
tions,  in vivo cardiovascular-specific knockout of SRF
results in embryonic death via cardiovascular failure due
to perturbations in normal muscle cytoarchitecture and
contractile assembly [11-13]. Numerous studies suggest
that disordered myogenic gene expression is due to defec-
tive SRF-mediated regulation of the smooth muscle cell-
specific regulatory factor myocardin [14-16].
SRF is a key regulator in development of the coronary vas-
culature. Coronary vasculature is derived from a transient
embryonic structure termed the proepicardium (PE) [17-
19]. The PE is characterized as a small, grape cluster-like
aggregate of cells developing at embryonic day 9 (E9)
from an extension of the septum transversum, lying
beneath the developing heart tube [20]. Cells of the PE
undergo an epithelial-to-mesenchymal transition (EMT)
and migrate over the surface of the heart. Some cells form
the primitive epicardium, and others appear to continue
to infiltrate into the subepicardial space. Once dispersed
into the heart tissue, these subepicardial mesenchymal
cells (SEMC) differentiate into the vascular smooth mus-
cle cells (VSMC) and vascular endothelial cells (VEC) that
comprise the coronary vasculature [18]. Previous work in
our laboratory has demonstrated expression of SRF within
cells of the PE and newly formed coronary vessels [21].
Landerholm and colleagues [22] have shown that inhibi-
tory SRF constructs block differentiation of avian PE to
VSMC, indicating a central role for SRF in differentiation
of PE-derived cells to VSMC.
A role for SRF in differentiation and function of VSMC is
well established, however, little is known about the role of
SRF in VEC [5,23]. Using primary HUVEC cultures, Chai
and colleagues [24] have shown that vascular endothelial
growth factor (VEGF) signalling pathways require SRF.
Endothelial cells in which SRF has been knocked down
fail to respond to intercellular VEGF signalling and show
abolished VEGF-induced in vitro angiogenesis, impaired
endothelial cell migration and proliferation, and inhib-
ited VEGF-induced actin polymerization and immediate
early gene expression.
These studies indicate that SRF likely plays an important
role in endothelial cell function. The in vivo role of
endothelial SRF, however, has not been addressed. There-
fore, in the current study we investigated the role of SRF in
VEC function by carrying out endothelial cell-specific
ablation of the SRF gene. Mice homozygous for Srf-Lox P
(Srff/f) alleles were bred to mice expressing the Cre recom-
binase protein under Tie2 promoter control (Tie2Cre+/-).
Tie2 is a vascular endothelial-specific tyrosine kinase
receptor for the angiopoietin family of vascular remodel-
ling factors [25,26]. The onset of Tie2Cre expression is
concurrent with the appearance of endothelium in E7.5
embryos and continues in adult tissues [27]. In embryos
expressing the mutant genotype Tie2Cre+/-Srff/f, we
observed hemorrhaging by E11.5 and near complete
lethality by E14.5. Examination of cardiac morphology
revealed smaller hearts as well as mild ventricular-septal
defects in mutant embryos as compared to wild-type lit-
termates. Immunohistochemical analysis suggests VEC
properly differentiated and assembled blood vessels.
However, the appearance of blood pools and segmented
blood vessels observed in embryos and yolk sacs of
E11.5–E13.5 embryos indicated disrupted vascular net-
works consistent with a defect in vascular remodelling.
Further analysis of yolk sac tissues by electron microscopy
demonstrated a lack of desmosomal-type junction com-
plexes as well as a paucity of collagen matrix between the
endodermal and mesodermal cell layers. E-cadherin pro-
tein detected by immunofluorescence showed a dramatic
decrease in signal along the apical brush-border of
endothelial cells in the extraembryonic endodermal layer
in yolk sac. These results provide the first in vivo evidence
in support of a role for SRF in endothelial cell function
and strongly suggest SRF is required for appropriate vascu-
lar remodelling.
Results
Conditional ablation of SRF protein in endothelium causes 
hemorrhaging in developing embryos
Inspection of embryos harvested from Tie2Cre+/-Srff/+ ×
Srff/f matings revealed internal hemorrhaging and blood
pooling consistent with loss of vascular organization (see
Figures 1 and 2). Mutant embryos appeared to developBMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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normally until E10.5 (compare Fig. 1A and 1B). However,
by E11.5 embryos expressing the mutant genotype
Tie2Cre+/-Srff/f  began to exhibit internal hemorrhaging
(Fig. 1D, arrowhead). The extent of bleeding continued to
progress with embryonic age (Fig. 1D, F, &1H). Wild-type
littermates showed intact vascular formation in contrast
to mutant embryos (compare Fig. 1G and 1H). Upon
closer examination, loss of vascular formation in the
mutant embryos becomes more obvious (see Figure 2). A
striking difference in the lack of apparent intact vascula-
ture was observed in Tie2Cre+/-Srff/f embryos compared to
wild-type littermates (Fig. 2, compare arrows in A and B,
C and D, E and F, and G and H). Blood pooling noted in
mutant embryos (Fig. 2B and 2F, asterisks) supports a loss
of vascular integrity.
Vascular fragmentation and internal hemorrhaging in  Tie2Cre+/-Srff/f embryos Figure 2
Vascular fragmentation and internal hemorrhaging 
in Tie2Cre+/-Srff/f embryos. Higher magnification photo-
graphs of whole unfixed, unstained mouse embryos as in Fig-
ure 1; embryos were examined at E12.5 (A, B) and E13.5 (C-
H). Tie2Cre+/-Srff/f mutant embryos (B, D, F, H) exhibited 
blood pooling (asterisks) and loss of visible vascular struc-
tures (arrowheads mark similar vessels; compare A & B, C & 
D, E & F, and G & H).
Tie2Cre+/-Srff/f embryos exhibit internal hemorrhaging Figure 1
Tie2Cre+/-Srff/f embryos exhibit internal hemorrhag-
ing. Photographs of whole unfixed, unstained mouse 
embryos at E10.5 (A, B), E11.5 (C, D), E12.5 (E, F) and E13.5 
(G, H). Tie2Cre+/-Srff/f mutant embryos (B, D, F, H) exhibited 
internal hemorrhaging compared to wild-type littermates (A, 
C, E, G). This effect progressed with increasing gestational 
age. E14.5 mutant embryos were grossly necrotic and unsuit-
able for analysis. Labelled boxes in Fig. 1 correspond to 
images in Fig. 2.; Lv = liver. Arrowhead marks minimal hem-
orrhaging observed in E11.5 embryos.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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Endothelial-specific disruption of the Srf gene during 
development causes embryonic lethality
The effect of endothelial-specific conditional ablation of
SRF protein expression during embryonic development
was evaluated. Loss of SRF expression in endothelial cells
was achieved by Tie2 driven-Cre recombinase-mediated
excision of the promoter region and first exon of Srf [11].
The conditional loss of Srf gene function in endothelial
cells resulted in embryonic death by E14.5 (see Table 1).
The majority of animals expressing the mutant genotype
Tie2Cre+/-Srff/f displayed an abnormal phenotype, and all
necrotic embryos collected expressed the mutant geno-
type. No animals with a mutant genotype were detected in
late gestation or at birth.
Hearts of Tie2Cre+/-Srff/f mutant embryos are smaller
Since SRF plays a central role in cardiac development, we
examined cardiac morphology of mutant embryos and
their wild-type littermates to ascertain whether observed
embryonic lethality was due to abnormal cardiac mor-
phogenesis. Embryos harvested from timed-pregnant
female mice were subjected to fixation for analysis of mor-
phology or for quantification of whole body and isolated
heart weights. Hearts of wild-type embryos correctly
formed atrial and ventricular chambers, and major vessels
of the atrial tree were present (see Figure 3). In contrast,
the muscular portion of the interventricular septum in
hearts of Tie2Cre+/-Srff/f  mutant genotype embryos
appeared reduced (Fig. 3B and 3D), potentially resulting
in ventricular-septal defects. Furthermore, enlarged ves-
sels were observed in mutant embryos, presumably due to
edema caused by vascular insufficiency (Fig. 3B and 3D,
asterisks). Analysis of endocardial cushion extracellular
matrix deposition revealed no difference between wild-
type and mutant littermates (alcian blue staining; data not
shown).
Hearts of mutant embryos appeared smaller than those of
wild-type littermates. To assess this observation, whole
body and isolated heart weights from E12.5 and E13.5
embryos were used to calculate heart weights as a percent-
age of overall body weight (Fig. 3E). The decrease in
apparent size of mutant hearts appeared as early as E12.5
(compare Fig. 3A with 3B); however, differences in whole
Hearts in mutant embryos are smaller and dysmorphic Figure 3
Hearts in mutant embryos are smaller and dysmorphic. Photomi-
crographs (40×) of transverse sections of mouse embryos at E12.5 (A, B) 
and E13.5 (C, D) stained with hematoxylin and eosin. Tie2Cre+/-Srff/f 
embryos exhibited reduced heart size by E12.5 (B, compare to A), which 
became more pronounced and consistent at E13.5 (D, compare to C). (E) 
Quantitation of heart size normalized to overall body weight revealed 
smaller hearts in both E12.5 (1.5 ± 0.4 vs. 1.08 ± 0.5, wild-type vs. mutant 
respectively; p = 0.054) and E13.5 embryos (1.4 ± 0.39% vs. 1.04 ± 0.17%, 
wild-type vs. mutant respectively; p = 0.021). Enlarged vessels apparently 
caused by edema due to vascular insufficiency were also noted in mutant 
embryos (asterisks). LV = left ventricle. Scale bar: 200 μm.
Table 1: Embryos with mutant genotype Tie2·Cre+/-Srff/f die by 
E14.5
Age Cre+/Srff/f Cre+/Srff/+ Cre-/Srff/f Cre-/Srff/+
E9.5 7 (0) 5 10 16
E10.5 12 (0) 14 (1) 15 26
E11.5 19 (1) 29 (2) 7 17
E12.5 24 (11) 21 17 7
E13.5 21 (19) 15 14 (2) 16
E14.5 10 (8) 3 3 4
E18.5 2 (2) 4 2 5
Neonate 0 18 20 13
Genotypic analysis of mouse embryos generated by crossing Tie2Cre+/
-Srff/+ male mice with Srff/f female mice. Numbers represent total 
embryos of each genotype; numbers in parentheses indicate mutant 
phenotype and grossly necrotic embryos. The conditional loss of Srf 
gene function in endothelial cells resulted in embryonic death by 
E14.5; no animals with mutant genotype were detected during late 
gestational age or at birth.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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body and heart weights at this age did not reach statistical
significance (1.5 ± 0.4 vs. 1.08 ± 0.5, wild-type vs. mutant
respectively; p = 0.054). Normalized heart weights from
E13.5 mutant embryos were reduced (1.4 ± 0.39% vs.
1.04 ± 0.17%, wild-type vs. mutant respectively; p =
0.021). Furthermore, immunofluorescent analysis of
phosphorylated histone H3 in E11.5 embryos revealed an
apparent reduction in the number of endocardial
endothelial cells undergoing proliferation (see Additional
file 1); no difference in apoptotic activity was detected
(cleaved caspase 3 immunofluorescent analysis; data not
shown). In contrast, the ratio of cardiomyocytes to total
cells was not different between wild-type and mutant
heart tissues (MF-20-immunolabelled cells as a percent-
age of total DAPI-positive nuclei; data not shown), sug-
gesting that the heart size differences noted are not due to
a selective loss of cardiomyocytes. E14.5 embryos with
mutant genotype were grossly necrotic and unsuitable for
analysis.
Yolk sac vasculature fails in Tie2Cre+/-Srff/f mutant 
embryos
The Tie2Cre construct is expressed in blood islands and
hemangioblasts within the extraembryonic yolk sac as
early as E7.5 [27]. Ablation of SRF protein expression in
yolk sac endothelial tissues caused blood vessel disorgan-
ization and subsequent vascular failure (see Figures 4 and
5). Yolk sac blood vessels appeared normal in both wild-
type and mutant animals until E11.5 (compare Fig. 4A
and 4B, C and 4D). In contrast, the yolk sacs of E12.5 and
E13.5 mutant embryos contained blood pools and frag-
mented blood vessels (Fig. 4F and 4H), consistent with
impaired vascular remodelling. Closer examination
revealed a web of poorly organized vessels (Fig. 5, com-
pare arrowheads in 5A, C, and 5E with 5B, D, and 5F).
SRF protein is localized within endothelial cells
To establish the expression of SRF within VEC of the cor-
onary vasculature, we performed double-label immun-
ofluorescent analysis of embryonic mouse heart.
Ventricular tissue was isolated from wild-type E16.5
mouse embryos, after coronary vessels have formed; cor-
responding Tie2Cre+/-Srff/f samples were not obtainable as
affected embryos die by E14.5. Sections of paraffin-
embedded ventricular tissue were immunolabelled for
both PECAM-1 and SRF proteins and examined by confo-
cal laser microscopy (see Figure 6). PECAM-1-stained
endothelial cells were clearly visible surrounding vessels
in ventricular myocardium as well as surrounding the
myocardial wall (Fig. 6A, arrowheads). Cardiomyocytes
showed robust SRF staining (Fig. 6A, asterisks). Higher
magnification imaging of a single focal plane showed
nuclear-localized SRF immunostaining (Fig. 6B, asterisks)
surrounded by PECAM-1 labelled endothelial cell mem-
branes (Fig. 6B, arrowheads).
SRF protein is decreased in VEC from Tie2Cre+/-Srff/f 
embryos
We analyzed embryonic vascular tissues using double-
label immunofluorescence microscopy to verify the loss
of SRF protein in affected cells (see Figure 7). Tissues from
E10.5 wild-type (Fig. 7A and 7B) and mutant (Fig. 7C and
7D) embryos were labelled with antibodies against SRF
and the VEC-marker PECAM-1 and analyzed by confocal
laser microscopy. Single-plane confocal images of blood
vessels were used to count the total number of VEC and
the number of VEC exhibiting SRF. Only those cells show-
ing SRF signal completely encircled by PECAM-1 staining
were scored as SRF-positive VEC (Fig. 7B, arrowhead).
Final numbers were expressed as percent SRF-positive VEC
Tie2Cre+/-Srff/f embryos exhibit yolk sac vascular failure Figure 4
Tie2Cre+/-Srff/f embryos exhibit yolk sac vascular fail-
ure. Photographs of whole unfixed, unstained intact yolk 
sacs containing mouse embryos at E10.5 (A, B), E11.5 (C, D), 
E12.5 (E, F) and E13.5 (G, H). Embryos with Tie2Cre+/-Srff/f 
genotype exhibited severely disrupted vascular networks at 
E12.5 (F) and E13.5 (H) as compared to wild-type littermates 
(E and G respectively). Labelled boxes in Fig. 4 correspond to 
images in Fig. 5.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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of the total counted for that vessel. A high proportion of
VEC in wild-type vessels were positive for SRF (84% ±
14.3) compared to mutant vessels (25% ± 15.7; p <
0.0000004; Fig. 7E).
Since the Tie2Cre  construct has been shown to be
expressed in endocardial endothelial cells, we analyzed
embryonic ventricular tissue for the presence or absence
of SRF protein using single-plane confocal images as
described above (see Additional file 2). We found a higher
number of endocardial endothelial cells exhibiting SRF-
positive immunofluorescence in wild-type as compared to
mutant tissues. No significant change in expression of SRF
protein was observed between wild-type or mutant
embryos in the epicardium (Additional file 2). Further-
more, to verify that SRF protein expression in cardiomyo-
cytes was not grossly affected by loss of SRF in endothelial
cells, we analyzed SRF protein expression in embryonic
heart tissues by immunodetection; however, no differ-
ences were noted (Additional file 2).
Early coronary vessel formation appears normal in mutant 
embryos
Coronary vessels begin to form at approximately E11.5,
with the coronary vascular network complete by E16.5
[28]. We examined early coronary vessel formation by
whole-mount immunohistochemical analysis of hearts
from E12.5 embryos (see Figure 8). We used the VEC-spe-
cific cell-surface marker PECAM-1 to label vascular struc-
tures in hearts from both wild-type and Tie2Cre+/-Srff/f
embryos. Vessels on the external ventral (Fig. 8A and 8B)
and dorsal (Fig. 8C and 8D) surfaces are visible and seem
intact in both wild-type and Tie2Cre+/-Srff/f embryos. This
observation indicates that initial formation of the coro-
nary vasculature is not affected by loss of SRF in endothe-
lial cells. However, we were unable to complete
assessment of the angiogenic remodelling responsible for
maturation of the coronary vascular network in mutant
embryos as they die and become grossly necrotic by
E14.5.
Yolk sac tissues from Tie2Cre+/-Srff/f embryos retain VEC 
despite fragmentation of blood vessels
The Tie2Cre construct is expressed in endodermal tissue
layers of the yolk sac as well as in VEC. Yolk sac vascular
Detection of SRF protein within vascular endothelial cells Figure 6
Detection of SRF protein within vascular endothelial 
cells. Single-plane confocal laser photomicrographs (A-630×, 
B-1,000×) of ventricular tissue from wild-type E16.5 mouse 
heart immunolabelled with the VEC marker PECAM-1 (red) 
and SRF (green). (A) PECAM-1-stained cells surround vessels 
as well as form the epicardium (arrowheads). Cardiomyo-
cytes within ventricular tissue show strong SRF staining 
(asterisks). (B) Endothelial cell-specific PECAM-1 (red; 
arrowheads) encircles the nuclear-localized SRF protein 
(green; asterisks). Scale bars: A = 40 μm; B = 4 μm.
Yolk sac tissues of Tie2Cre+/-Srff/f embryos display vascular  disintegration and blood pooling Figure 5
Yolk sac tissues of Tie2Cre+/-Srff/f embryos display vas-
cular disintegration and blood pooling. Photographs of 
whole unfixed, unstained intact yolk sacs containing mouse 
embryos at E12.5 (A, B, C, D) and E13.5 (E, F). Yolk sac tis-
sues from mutant embryos showed disorganized vascular 
networks at E12.5 (B) that become more pronounced at 
E13.5 (D, F arrowheads). Blood pools (B, asterisks) were also 
observed in mutant yolk sac tissues.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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networks undergo extensive remodelling during the
course of embryogenesis. Based on our observation of
fragmented yolk sac vessels, we sought to determine the
status of VEC within yolk sac tissues. We looked for the
presence of VEC within yolk sac tissues by immunolabel-
ling whole mount samples of E13.5 wild-type and
Tie2Cre+/-Srff/f  yolk sac tissues with the VEC marker
PECAM-1 (see Figure 9). Yolk sac tissues from embryos
lacking SRF in endothelium demonstrated the presence of
appropriately differentiated VEC; however, blood vessels
in SRF-null yolk sac tissues were almost completely disin-
tegrated by this age. Remnants of presumed blood vessels
could still be seen (Fig. 9B, arrowheads), suggesting
incomplete vessel remodelling or inappropriate mainte-
nance of existing vessels.
Furthermore, cross-sectional examination of Tie2Cre+/-
Srff/f yolk sac tissues revealed delamination of the endo-
dermal and mesodermal components of the yolk sac lay-
ers (Fig. 9C and 9D). Tissues immunolabelled by the VEC
marker PECAM-1 showed separation of the endodermal
and mesodermal tissues (compare Fig. 9C and 9D, aster-
isks). Also, some areas of laminar separation were
observed to contain blood cells, suggesting these areas
derived from either blood vessels or blood islands. Quan-
titation of the linear length of laminar separation in cross-
sections shows that yolk sac tissues from mutant animals
have a greater degree of laminar separation than wild-type
littermates (see Fig. 9E; 16.3 ± 10.8% vs. 62.0 ± 10.4%
wild-type vs. mutant; p = 0.003).
Mutant yolk sac tissues lack cell-cell junctions and intra-
laminar collagen deposition
Samples of yolk sac tissues from wild-type and Tie2Cre+/-
Srff/f embryos were processed for analysis by transmission
electron microscopy (see Figure 10). Wild-type tissues
contained desmosomal-type junction complexes that
were absent in Tie2Cre+/-Srff/f tissues (Fig. 10B, arrow-
heads; compare to Fig. 10E). Furthermore, collagen depo-
sition in the extracellular matrix between the endodermal
and mesodermal yolk sac layers was greatly diminished
(Fig. 10C, arrowheads; compare to Fig. 10F). Sub-cellular
Early coronary vessel development in Tie2Cre+/-Srff/f embryos  appears normal compared to wild-type littermates Figure 8
Early coronary vessel development in Tie2Cre+/-Srff/f 
embryos appears normal compared to wild-type lit-
termates. Photographs of whole-mount immunostained 
wild-type (A, C) and Tie2Cre+/-Srff/f (B, D) hearts. Samples 
were stained with the endothelial cell marker PECAM-1 to 
detect vascular structures. Vessels on ventral (A, B) and dor-
sal (C, D) heart surfaces were clearly visible, indicating appar-
ently normal assembly of initial coronary vasculature. LV = 
left ventricle.
SRF protein is decreased in endothelial tissues of Tie2Cre+/- Srff/f embryos Figure 7
SRF protein is decreased in endothelial tissues of Tie2Cre+/-Srff/f 
embryos. Photomicrographs (A, C:1,000×; B, D:4,000×) of cross-sections 
of blood vessels from E10.5 wild-type (A, B) and mutant (C, D) embryos 
were used to count the total number of VEC and the number of VEC 
exhibiting SRF (boxes in A, C correspond to images in C, D respectively). 
Tissues were labelled with antibodies against SRF (green) and the VEC-
marker PECAM-1 (red) and analyzed using single-plane confocal laser 
microscopy (blue = Topro3 nuclear staining). Only those cells showing 
SRF signal completely encircled by PECAM-1 staining were scored as SRF-
positive VEC (B, D arrowheads). Not all VEC displayed detectable SRF 
protein (A, arrow). Final numbers were expressed as percent SRF-positive 
VEC of the total counted for that vessel (E): 84 ± 14.3 vs. 25 ± 15.7, wild-
type vs. mutant respectively; *p = 0.0000004, student's t test. Scale bars: A, 
C = 30 μm; B, D = 10 μm.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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elements of both endodermal and mesodermal cells in
mutant tissue appeared largely normal, and did not dis-
play signs of necrosis nor apoptotic bodies. This observa-
tion suggests that the loss of cell-cell adhesion complexes
is not due to gross disintegration of the yolk sac tissue as
a whole, but rather is a consequence of SRF deprivation.
E-Cadherin is decreased in Tie2Cre+/-Srff/f embryonic yolk 
sac tissues
We sought to confirm our electron microscopy observa-
tions by immunofluorescent labelling of junctional com-
plexes by E-cadherin (see Figure 11). Wild-type and
Tie2Cre+/-Srff/f yolk sac tissues were double-labelled with
the endothelial cell marker PECAM-1 and E-cadherin and
subjected to fluorescent microscopy for analysis. Wild-
type endodermal cells displayed intense E-cadherin local-
ization along the apical brush-border surface, a staining
pattern largely absent from mutant tissues (compare Fig.
11A and 11B). Closer examination by confocal laser
microscopy confirmed the lack of detectable E-cadherin
(compare Fig. 11C and 11D, arrowheads).
Discussion
Numerous studies have shown that SRF is a critical tran-
scriptional regulator of genes important for VSMC differ-
entiation and development, and therefore a key regulator
Lack of junctional complexes and collagen deposition  revealed by electron microscopy analysis of yolk sac tissues Figure 10
Lack of junctional complexes and collagen deposition 
revealed by electron microscopy analysis of yolk sac 
tissues. Yolk sac tissues from wild-type (A, B, C) and 
Tie2Cre+/-Srff/f (D, E, F) embryos were subjected to transmis-
sion electron microscopy to assess ultrastructural detail. 
Desmosomal-type junctional complexes are observed in 
wild-type tissue (B arrowheads) but not in mutant tissue (E). 
Intralaminar collagen deposition occurs normally between 
endodermal and mesodermal cell layers in wild-type (A, C) 
but not mutant (D, F) tissues. Arrowheads in C denote longi-
tudinal and cross-sectional views of individual collagen fibrils. 
Boxes in A and D correspond to images in B and E, respec-
tively; asterisks in A and D correspond to images in C and F, 
respectively; scale bars: A, D = 1 μm; B, C, E, F = 0.2 μm.
Tie2Cre+/-Srff/f yolk sac tissues show loss of blood vessel integ- rity and separation of dermal layers Figure 9
Tie2Cre+/-Srff/f yolk sac tissues show loss of blood ves-
sel integrity and separation of dermal layers. Yolk sac 
tissues immunostained with VEC-specific marker PECAM-1 
to label endothelial cells and vascular structures. Photo-
graphs of wild-type (A) and Tie2Cre+/-Srff/f (B) whole yolk sac 
at E13.5; arrowheads (B) mark apparent blood vessel rem-
nants in mutant yolk sac tissue. Photomicrographs (200×) of 
cross-sections of wild-type (C) and Tie2Cre+/-Srff/f (D and E) 
yolk sac at E13.5 immunolabelled for PECAM-1 (brown-gray 
= PECAM-1, red = neutral red counterstain). Normal cellular 
layers of endoderm (Ed) and extraembryonic mesoderm 
(Md) are tightly associated in wild-type as compared to 
mutant yolk sac tissue. Asterisks mark areas of inappropriate 
tissue layer separation in Tie2Cre+/-Srff/f yolk sac (D). (E) 
Quantitation of laminar separation in cross-sections of yolk 
sac tissues as in C and D revealed increased delamination in 
mutant animals (16.3 ± 10.8% vs. 62.0 ± 10.4%, wild-type vs. 
mutant respectively; p = 0.0031). Scale bar: C, D = 50 μm.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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of vascular development. Consistent with this, SRF is
required for differentiation of PE-derived precursors to
VSMC during coronary vascular development [22]. We
have previously shown, however, that SRF is expressed in
the PE prior to detectable expression of VSMC markers
[21], raising the possibility that SRF may play a role in dif-
ferentiation of PE-derived coronary VEC as well. To begin
to address this idea, we have sought to investigate the role
of SRF in endothelial cells in vivo, and whether endothelial
SRF is required for normal vascular development.
Towards that end, we crossed mice expressing Cre recom-
binase under the VEC-specific Tie2-derived promoter with
mice carrying floxed Srf alleles. Our data demonstrate that
SRF plays a crucial role in appropriate VEC function
beginning early in embryonic development.
Mutant embryos lacking SRF expression in VEC die by
E14.5. Examination of heart structure reveals that hearts
of Tie2Cre+/-Srff/f embryos undergo looping and chamber
formation; however, hearts of mutant embryos are meas-
urably smaller with increasing gestational age compared
to wild-type littermates. We did not detect a difference in
the percentage of cardiomyocytes in heart tissue between
wild-type and mutant embryos despite noting a small
decrease in cardiomyocyte proliferation. Analysis of apop-
totic activity by cleaved caspase 3 immunoreactivity also
showed no discernible difference between wild-type and
mutant embryos. Based on the well-documented specifi-
city of the Tie2Cre  driver, it is unlikely that the small
decrease in cardiomyocyte proliferation observed is due to
direct Cre-mediated excision of the Srf allele in cardiomy-
ocytes [27]. One possible explanation for the reduction in
cardiomyocyte proliferation in mutant embryos is that
there is a defect in signalling to cardiomyocytes. In sup-
port of this idea, a variety of studies have demonstrated
the importance of reciprocal signalling pathways between
endocardial endothelial cells and the developing myocar-
dium (for review see [29]). This raises the possibility that
impaired signalling from SRF-null endocardial endothe-
lial cells is contributing to reduced cardiomyocyte prolif-
eration and the overall decrease in heart size observed in
Tie2Cre+/-Srff/f embryos. The apparent reduction in endo-
cardial cell proliferation we observed in mutant embryos
further suggests that loss of SRF in endothelial cells results
in impaired endocardial endothelial cell function; how-
ever, which endothelial signalling pathways are impaired
in SRF-null cells remains to be determined.
Endocardial cushion tissues are present; however, septal
tissues appear poorly formed in mutant embryos, and in
some cases exhibit a failure to form ventricular septa. Nev-
ertheless, in utero lethality lacking gross defects in heart
structure supports the idea of vascular failure as a cause of
death. Lethal vessel malfunction may be occurring within
the atrial tree, embryonic or extra-embryonic vasculature,
or yolk sac vasculature. Consistent with this, mutant
embryos exhibit hemorrhaging within the head, abdo-
men, and limbs as early as E12.5, a time when blood ves-
sel remodelling is occurring. Yolk sac vasculature is also
disrupted, suggesting a common mechanism of vessel
malfunction in both embryonic and extra-embryonic tis-
sues.
Initial vessel formation in the heart begins at approxi-
mately E11.5 and is completed with establishment of
mature coronary arteries by E16.5 [28]. Early coronary
vasculogenesis appears to occur normally in embryos
lacking SRF in VEC as shown by the presence of PECAM-
1-positive vessels in hearts from both wild-type and
mutant E12.5 embryos. Nevertheless, mutant embryos die
by E14.5, leaving the issue of SRF's role in coronary vascu-
lature remodelling and maturation unclear. Determining
the precise requirement for SRF in VEC specification is
E-Cadherin localization is disrupted in yolk sac tissues of  Tie2Cre+/-Srff/f embryos Figure 11
E-Cadherin localization is disrupted in yolk sac tis-
sues of Tie2Cre+/-Srff/f embryos. Photomicrographs of 
wild-type (A, C; 400×) and mutant (B, D; 2,000×) yolk sac tis-
sues stained for PECAM (red) and E-cadherin (green). 
Immunofluorescent analysis revealed a decrease in detectable 
E-cadherin protein in mutant samples. Robust E-cadherin 
staining is observed in the endodermal (Ed) but not mesoder-
mal (Md) layer of wild-type yolk sac (A). In contrast, very lit-
tle E-cadherin staining can be detected in yolk sac from 
Tie2Cre+/-Srff/f embryos (B). Single-plane confocal microscopy 
(C, D; 4,000×) confirms the lack of E-cadherin immunostain-
ing at the apical brush-border surface of mutant yolk sac 
endodermal cells (compare A and B, arrowheads). Blue stain 
in A and B is DAPI nuclear stain. Scale bars: A, B = 50 μm; C, 
D = 7.5 μm.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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also complex since the Tie2Cre construct begins expres-
sion presumably after hemangioblast specification. Exam-
ination of blood smears from E12.5 embryos reveals no
grossly observable differences between wild-type and
mutant samples (data not shown). This may suggest that
early VEC progenitors in the yolk sac are not influenced by
excision of the Srf gene; however since the SRF protein has
a relatively long half-life [30], we cannot rule out the pos-
sibility that residual SRF protein levels remain sufficient to
sustain specification and differentiation of early VEC.
These questions are better suited to investigation using in
vitro model systems of VEC specification and differentia-
tion, and are the object of ongoing studies.
While it is evident that SRF protein levels are reduced in
VEC of mutant embryos, detectable SRF protein in both
wild-type and Tie2Cre+/-Srff/f embryos suggests a signifi-
cant degree of mosaicism. Also, the stringency of our
method for quantitation of SRF protein in VEC may result
in an underestimation of the number of cells displaying
detectable SRF protein. We have observed varying degrees
of Srf-floxed allele excision efficiency based on the Cre
recombinase driver, as well as possible variability from
cell to cell. This results in a mosaic expression pattern
between individual cells; however, the phenotypic effects
of the excision still manifest in the tissue as a whole. Nev-
ertheless, it is likely that more complete ablation may
result in a more severe phenotype.
Yolk sac vascular networks undergo extensive remodelling
during the course of embryogenesis. In our study, yolk sac
vascular networks appear to form normally, echoing what
was observed in initial coronary vessel development.
However, yolk sac vascular networks became severely dis-
rupted by E12.5, indicating a failure of the blood vessels
to remodel and mature. Disintegration of yolk sac vascu-
lature was accompanied by separation of endodermal and
mesodermal cell layers. Further analysis revealed a lack of
desmosomal junctions and intralaminar collagen as well
as dramatic loss of E-cadherin in cells of the endodermal
layer. Anchoring-type desmosomal junctions are plentiful
in tissues subject to persistent mechanical stress, such as
yolk sac, skin, and heart. Proper junction formation relies
on appropriate expression of cytoskeletal and cell surface
anchoring proteins such as actins, cadherins, and
integrins. Recent work in our laboratory has shown that
SRF-null cardiomyocytes have decreased levels of a
number of genes associated with cell adhesion and
cytoskeletal function including integrins β1 and α9, tight
junction protein ZO-1, and protocadherins 7 and 18 [10],
raising the possibility that the same genes may be affected
in SRF-null endothelial cells, resulting in deficient cell-cell
contacts.
Previous research has shown cadherins are also required
for pericyte-endothelial interactions during angiogenic
sprouting [31]. Furthermore, VE-cadherin, a major com-
ponent of adherens junctions between endothelial cells,
has been shown to promote angiogenesis [32]. Consistent
with these findings, putative SRF-binding sites have been
identified in the VE-cadherin-2/protocadherin12 [33],
integrin-β1, integrin-β1 binding protein 2,
protocadherin7 and protocadherin18 genes [10]. These
observations suggest the involvement of SRF in regulation
of cell-cell contacts; however as of yet, no experimental
studies have addressed whether SRF is a significant player
in these interactions, or whether SRF is a regulator of these
genes in VEC.
Our results also raise the possibility that SRF may play a
role in periendothelial cell/pericyte recruitment and ves-
sel stabilization via involvement in angiopoietin (Ang)
signalling. PECAM staining of yolk sac from Ang1-null
mice shows a loss of vascular integrity similar to that seen
in our study [34]. Ang1, a member of the angiopoietin
family of ligands [25], activates the Tie2 receptor by bind-
ing to it and inducing its tyrosine phosphorylation. Ang1
is generated by non-endothelial cells, such as VSMC and
other vascular pericytes recruited to vessels. Early in devel-
opment between E9 to E11, Ang1 is found most promi-
nently in the heart myocardium surrounding the
endocardium. Later, it becomes more widely distributed,
most often detected in the mesenchyme surrounding
developing vessels and in close association with endothe-
lial cells. Ang1-dependent vessel stabilization occurs by
supporting reciprocal interactions between the vascular
endothelium, pericytes, and surrounding extracellular
matrix and mesenchyme [35]. Tie2 mediates Ang1 signal-
ling via several known signalling pathways, including the
Akt, RhoA/Rac1, MAPK, and ERK1/2 pathways [25]. Since
SRF is a known mediator of all these pathways [36-39],
this suggests that a role for SRF in Tie-2 mediated ang-
iogenic remodelling may also lie as a downstream effector
in the Ang1/2 signalling cascade in endothelial cells.
The results presented here unequivocally establish SRF as
a critical regulator of endothelial cell function in vivo and
indicate that appropriate SRF protein expression is
required for remodelling of vascular networks. However,
these results do not directly address the role of SRF in
endothelial specification and differentiation since the
Tie2Cre construct is expressed in differentiated endothe-
lial cells. Our results suggest that disruption of anchoring-
type proteins may play a significant role in the observed
vascular failure, although the precise underlying molecu-
lar mechanisms remain to be addressed. Development of
reagents that allow functional analyses of SRF loss of in
endothelial precursors as well as vessel maturation will be
required to more fully address these questions.BMC Developmental Biology 2008, 8:65 http://www.biomedcentral.com/1471-213X/8/65
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Conclusion
Our study provides the first in vivo experimental evidence
of a role for SRF in VEC function during embryonic devel-
opment. Mouse embryos lacking SRF expression in
endothelial cells die mid-gestation due to apparent vascu-
lar insufficiency. Initial analysis suggests a lethal malfunc-
tion in angiogenic remodelling and vessel maintenance.
The extent to which this malfunction is due to failed recip-
rocal signalling between VEC and surrounding mesen-
chyme or perhaps incomplete vascular pericyte
recruitment remains to be determined.
Methods
Mice and Genotyping
The Tie2Cre and Srff/f transgenic mouse lines have been
previously described [27,40]. Previous work has demon-
strated that expression of the Tie2Cre gene begins early at
E7.5; expression has been noted in all endothelial and
endocardial tissues as well as some hematopoietic tissues
[27]. Embryos were generated by timed mating, designat-
ing embryonic day 0.5 (E0.5) as noon on the day a vaginal
plug was observed. Genotyping was performed under
standard protocols using genomic DNA isolated from
embryonic yolk sac, amnionic membrane, or tail tissue.
Primers used were: Tie2Cre fwd 5'-GTTCGCAAGAACCT-
GATGGACA-3' and rev 5'-CTAGAGCCTGTTTT-
GCACGTTC-3';  Srff/f  fwd 5'-
TGCTTACTGGAAAGCTCATGG-3' and rev 5'-TGCT-
GGTTTGGmCATCAACT-3'; HPRT fwd 5'-AGCGCAAGTT-
GAATCTGC-3' and rev 5'-AGCGACAATCTACCAGAG-3'.
All procedures were in compliance with the Institutional
Animal Care and Use Committee of the Medical College
of Wisconsin.
Quantitation of embryonic total body and isolated heart 
weights
Embryos were harvested from timed pregnant females
and placed individually on a clean glass slide for weight
determination; excess buffer fluid was absorbed by wick-
ing with tissues prior to weighing. After whole body
weight was recorded, the heart was dissected out and
weighed separately. Amnionic membrane was reserved for
genotypic analysis.
Histology, Immunohistochemistry, and Microscopy
Embryos were harvested from timed pregnant females,
photographed, and then fixed in either 4% paraformalde-
hyde/PBS or Tris-buffered zinc fixative (0.1 M Tris pH7.4
with 3.2 mM calcium acetate, 22.8 mM zinc acetate, and
36.7 mM zinc chloride). Yolk sac tissues selected for
whole mount immunostaining were processed as
described [41]. After staining, tissues were photographed
and further processed for paraffin-embedding. All other
samples were processed for paraffin-embedding, and sub-
sequent sections (7 μm) were used for either hematoxylin
& eosin staining, alcian blue staining, immunohistochem-
istry or confocal microscopy as described [42,43]. Rea-
gents utilized were: anti-E-cadherin (BD Bioscience, clone
36); anti-sarcomeric myosin (University of Iowa Develop-
mental Studies Hybridoma Bank, clone MF-20); anti-
PECAM-1 (BD Biosciences, clone MEC13.3); anti-phos-
pho-Histone H3 (Millipore, Ser-10); anti-SRF (Protein-
Tech custom). Digital image capture was performed using
a Nikon SM2100 microscope with a Nikon CoolPix995
camera (whole mount), Nikon Eclipse TE300 microscope
with a SpotII digital camera (tissue sections), or a Leica
TCS SP2 laser scanning confocal microscope imaging sys-
tem (confocal imaging). For electron microscopy,
embryos were harvested from timed pregnant females and
fixed in glutaraldehyde/sodium arsenate buffer. Subse-
quent processing and image collection were performed by
the Electron Microscopy Core Facility at the Medical Col-
lege of Wisconsin.
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Additional file 1
Mitotic marker phospho Histone H3 appears decreased in Tie2Cre+/-
Srff/f endocardial endothelial cells compared to wild-type littermates. 
Single-plane confocal images (630×) of sections of E11.5 mouse embry-
onic ventricular tissue (A, B) immunostained for endocardial endothelial 
cells (PECAM-1; red), cardiomyocytes (MF-20; green), and proliferating 
cells (phospho Histone H3, PhH3; blue). (C) Quantitation of PhH3-pos-
itive nuclei in either endocardial endothelial cells or cardiomyocytes (total 
PhH3-positive cells immunolabelled by PECAM-1 or MF-20 over four vis-
ual fields). Tie2Cre+/-Srff/f mutant embryos exhibited reduced PhH3 
immunoreactivity in endocardial endothelial cells compared to wild-type 
embryos, indicating a decrease in proliferation (arrowheads; C, left 
graph). MF-20-positive cardiomyocytes in mutant tissue exhibit a mild 
decrease in PhH3 immunostaining (arrows; C, right graph), which is con-
sistent with the apparent reduction in overall myocardial size. Decreased 
myocardial mass is likely a secondary effect of inadequate signalling from 
SRF-null endocardial endothelial cells rather than Cre-mediated direct 
excision of SRF in cardiomyocytes. Also, consistent with previous reports 
(Nelson et al., Circ. Res. 2004), presumed epicardium is negative for 
PECAM-1 staining in both wild-type and mutant embryos (asterisks). 
Scale bar: A, B = 30 μm.
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